Published in Mol Med Today on February 01, 2000
Expression and characterization of a single-chain polypeptide analogue of the human immunodeficiency virus type 1 gp120-CD4 receptor complex. J Virol (2000) 1.85
M cell-targeted DNA vaccination. Proc Natl Acad Sci U S A (2001) 1.10
CD8(+)-T-cell response to secreted and nonsecreted antigens delivered by recombinant Listeria monocytogenes during secondary infection. Infect Immun (2002) 1.09
Induction of immune response in BALB/c mice with a DNA vaccine encoding bacterioferritin or P39 of Brucella spp. Infect Immun (2001) 1.05
An oral recombinant Salmonella enterica serovar Typhimurium mutant elicits systemic antigen-specific CD8+ T cell cytokine responses in mice. Gut Pathog (2009) 0.92
Use of a recombinant Salmonella enterica serovar Typhimurium strain expressing C-Raf for protection against C-Raf induced lung adenoma in mice. BMC Cancer (2005) 0.92
Yersinia enterocolitica as a vehicle for a naked DNA vaccine encoding Brucella abortus bacterioferritin or P39 antigen. Infect Immun (2002) 0.89
Requirement of siderophore biosynthesis for plant colonization by Salmonella enterica. Appl Environ Microbiol (2012) 0.89
Construction of a tetR-integrated Salmonella enterica serovar Typhi CVD908 strain that tightly controls expression of the major merozoite surface protein of Plasmodium falciparum for applications in human Vaccine production. Infect Immun (2002) 0.88
Live-Attenuated Bacterial Vectors: Tools for Vaccine and Therapeutic Agent Delivery. Vaccines (Basel) (2015) 0.85
In Vivo Programmed Gene Expression Based on Artificial Quorum Networks. Appl Environ Microbiol (2015) 0.84
Robust immunity to an auxotrophic Mycobacterium bovis BCG-VLP prime-boost HIV vaccine candidate in a nonhuman primate model. J Virol (2013) 0.83
Recombinant vaccines and the development of new vaccine strategies. Braz J Med Biol Res (2012) 0.83
Recombinant Salmonella enterica serovar Typhimurium as a vaccine vector for HIV-1 Gag. Viruses (2013) 0.80
Heterologous expression of Brucella abortus GroEL heat-shock protein in Lactococcus lactis. Microb Cell Fact (2006) 0.80
Comparative immunological evaluation of recombinant Salmonella Typhimurium strains expressing model antigens as live oral vaccines. BMC Immunol (2012) 0.79
Exploiting cholera vaccines as a versatile antigen delivery platform. Biotechnol Lett (2007) 0.79
Modulation of plasmid DNA vaccine antigen clearance by caspase 12 RNA interference potentiates vaccination. Clin Vaccine Immunol (2011) 0.79
Recombinant Salmonella Bacteria Vectoring HIV/AIDS Vaccines. Open Virol J (2013) 0.79
HPV16L1-attenuated Shigella recombinant vaccine induced strong vaginal and systemic immune responses in guinea pig model. Hum Vaccin Immunother (2014) 0.78
Protective immunity to Listeria monocytogenes infection mediated by recombinant Listeria innocua harboring the VGC locus. PLoS One (2012) 0.78
Live bacterial vaccine vectors: an overview. Braz J Microbiol (2015) 0.77
Enhanced priming of adaptive immunity by Mycobacterium smegmatis mutants with high-level protein secretion. Clin Vaccine Immunol (2012) 0.76
Isolation of monoclonal antibodies specific for human c-myc proto-oncogene product. Mol Cell Biol (1985) 25.52
Isolation of monoclonal antibodies specific for products of avian oncogene myb. Mol Cell Biol (1984) 2.50
Epitope mapping and topology of baculovirus-expressed HIV-1 gp160 determined with a panel of murine monoclonal antibodies. AIDS Res Hum Retroviruses (1994) 2.47
Which gp160 vaccine? Nature (1993) 2.27
Comparison of the safety and immunogenicity of delta aroC delta aroD and delta cya delta crp Salmonella typhi strains in adult volunteers. Infect Immun (1992) 2.23
Expression and characterization of a single-chain polypeptide analogue of the human immunodeficiency virus type 1 gp120-CD4 receptor complex. J Virol (2000) 1.85
The oxidation state of iron at high pressure. Science (1969) 1.85
Immunological evidence for interactions between the first, second, and fifth conserved domains of the gp120 surface glycoprotein of human immunodeficiency virus type 1. J Virol (1994) 1.72
Purification of functional, determinant-specific, idiotype-bearing murine T cells. J Exp Med (1978) 1.70
Clinical acceptability and immunogenicity of CVD 908 Salmonella typhi vaccine strain. Vaccine (1992) 1.69
Regulation of host immune responses by modification of Salmonella virulence genes. Nat Med (1998) 1.59
Further consideration of the clonal nature of Salmonella typhi: evaluation of molecular and clinical characteristics of strains from Indonesia and Peru. J Clin Microbiol (1992) 1.50
Murine B-cell subpopulations responsive to T-dependent and T-independent antigens. J Exp Med (1976) 1.49
Antibodies to the scrapie protein decorate prion rods. J Immunol (1985) 1.46
Antigenic properties of the human immunodeficiency virus envelope during cell-cell fusion. J Virol (2001) 1.45
Construction and characterization of attenuated delta aroA delta virG Shigella flexneri 2a strain CVD 1203, a prototype live oral vaccine. Infect Immun (1994) 1.43
Expression of recombinant enterotoxigenic Escherichia coli colonization factor antigen I by Salmonella typhimurium elicits a biphasic T helper cell response. Infect Immun (1999) 1.30
Baculovirus-derived human immunodeficiency virus type 1 virus-like particles activate dendritic cells and induce ex vivo T-cell responses. J Virol (2006) 1.29
Actin polymerization and pseudopod reorganization accompany anti-CD3-induced growth arrest in Jurkat T cells. J Immunol (1993) 1.26
Release of tumor necrosis factor alpha in response to Vibrio vulnificus capsular polysaccharide in in vivo and in vitro models. Infect Immun (1997) 1.15
Immune responses to novel Escherichia coli and Salmonella typhimurium vectors that express colonization factor antigen I (CFA/I) of enterotoxigenic E. coli in the absence of the CFA/I positive regulator cfaR. Infect Immun (1995) 1.14
Phage display of intact domains at high copy number: a system based on SOC, the small outer capsid protein of bacteriophage T4. Protein Sci (1996) 1.14
Antigen-specific molecules from murine T lymphocytes and T cell hybridomas. Mol Immunol (1980) 1.13
Idiotype profile of an immune response. I. Contrasts in idiotypic dominance between primary and secondary responses and between IgM and IgG plaque-forming cells. J Exp Med (1981) 1.10
Differential early interactions between Salmonella enterica serovar Typhi and two other pathogenic Salmonella serovars with intestinal epithelial cells. Infect Immun (1998) 1.07
Strengthening capacity, collaboration and quality of clinical research in Africa: EDCTP Networks of Excellence. Tanzan J Health Res (2009) 1.06
Oral immunization with a Salmonella typhimurium vaccine vector expressing recombinant enterotoxigenic Escherichia coli K99 fimbriae elicits elevated antibody titers for protective immunity. Infect Immun (1998) 1.05
Intracellular delivery of a cytolytic T-lymphocyte epitope peptide by pertussis toxin to major histocompatibility complex class I without involvement of the cytosolic class I antigen processing pathway. Infect Immun (1999) 1.04
Idiotype connectance in the immune system. I. Expression of a cross-reactive idiotype on induced anti-p-azophenylarsonate antibodies and on endogenous antibodies not specific for arsonate. J Exp Med (1983) 1.03
Impact of MHC class I alleles on the M. tuberculosis antigen-specific CD8+ T-cell response in patients with pulmonary tuberculosis. Genes Immun (2007) 1.02
A new monoclonal antibody, mAb 4A12, identifies a role for the glycosaminoglycan (GAG) binding domain of RANTES in the antiviral effect against HIV-1 and intracellular Ca2+ signaling. J Exp Med (1998) 1.01
Differences in the antibody response to human immunodeficiency virus-1 envelope glycoprotein (gp160) in infected laboratory workers and vaccinees. J Clin Invest (1993) 0.98
Carrier-directed anti-hapten responses by B-cell subsets. J Exp Med (1977) 0.95
Multistep transformation by defined fragments of herpes simplex virus type 2 DNA: oncogenic region and its gene product. Proc Natl Acad Sci U S A (1985) 0.93
A hidden region in the third variable domain of HIV-1 IIIB gp120 identified by a monoclonal antibody. AIDS Res Hum Retroviruses (1993) 0.92
Construction and immunogenicity of Salmonella typhimurium vaccine vectors that express HIV-1 gp120. Vaccine (1995) 0.91
Rosette formation between murine lymphocytes and erythrocytes. A new locus in the H-2 region. J Exp Med (1979) 0.90
Th2 polarization in peripheral blood mononuclear cells from human immunodeficiency virus (HIV)-infected subjects, as activated by HIV virus-like particles. J Virol (2008) 0.90
The anatomy of an antigen molecule: functional subregions of L-tyrosine-p-azobenzenearsonate. Mol Immunol (1984) 0.90
Arsonate-specific murine T cell clones. I. Genetic control and antigen specificity. J Exp Med (1983) 0.90
Lipopolysaccharide from an Escherichia coli htrB msbB mutant induces high levels of MIP-1 alpha and MIP-1 beta secretion without inducing TNF-alpha and IL-1 beta. J Hum Virol (1999) 0.90
Soluble complexes of regulated upon activation, normal T cells expressed and secreted (RANTES) and glycosaminoglycans suppress HIV-1 infection but do not induce Ca(2+) signaling. Proc Natl Acad Sci U S A (1999) 0.89
Vaccination with a Shigella DNA vaccine vector induces antigen-specific CD8(+) T cells and antiviral protective immunity. J Virol (2001) 0.89
Complement-dependent and -independent pathways of T cell-B cell cooperation. J Immunol (1977) 0.88
Mucosal and systemic HIV-1 Env-specific CD8(+) T-cells develop after intragastric vaccination with a Salmonella Env DNA vaccine vector. Vaccine (2001) 0.88
Antigen specific T cell hybrids--II. T cell hybrids which bind azobenzenearsonate. Mol Immunol (1980) 0.87
Optimization of live oral Salmonella-HIV-1 vaccine vectors for the induction of HIV-specific mucosal and systemic immune responses. J Biotechnol (1996) 0.86
Immunogenicity of DNA vaccines that direct the coincident expression of the 120 kDa glycoprotein of human immunodeficiency virus and the catalytic domain of cholera toxin. Vaccine (2003) 0.86
Progress toward the development of a bacterial vaccine vector that induces high-titer long-lived broadly neutralizing antibodies against HIV-1. FEMS Immunol Med Microbiol (2003) 0.86
In vitro effects of anti-HIV immunotoxins directed against multiple epitopes on HIV type 1 envelope glycoprotein 160. AIDS Res Hum Retroviruses (1996) 0.86
Activation of B cell subsets by T-dependent and T-independent antigens. Adv Exp Med Biol (1978) 0.85
A hemolytic plaque assay for activated murine T cells. J Exp Med (1979) 0.85
Perforin-low memory CD8+ cells are the predominant T cells in normal humans that synthesize the beta -chemokine macrophage inflammatory protein-1beta. Proc Natl Acad Sci U S A (2001) 0.85
Induction of mucosal and systemic responses against human immunodeficiency virus type 1 glycoprotein 120 in mice after oral immunization with a single dose of a Salmonella-HIV vector. AIDS Res Hum Retroviruses (1997) 0.85
A Tat subunit vaccine confers protective immunity against the immune-modulating activity of the human immunodeficiency virus type-1 Tat protein in mice. Proc Natl Acad Sci U S A (2002) 0.84
The effect of pressure on the oxidation state of iron, ii. Oxygen ligands. Proc Natl Acad Sci U S A (1968) 0.84
Improved measurement of calcium mobilization by flow cytometry. Biotechniques (1997) 0.82
Construction and characterization of a Salmonella typhi-based human immunodeficiency virus type 1 vector vaccine. Vaccine (1995) 0.82
The GP120 molecule of HIV-1 and its interaction with T cells. Curr Med Chem (2010) 0.81
Choroid plexus carcinoma presenting as an intraparenchymal mass. J Neurosurg (2001) 0.80
Radionuclide kymography for the assessment of regional myocardial wall motion. J Nucl Med (1978) 0.79
Facilitation of macrophage-mediated destruction of allogeneic fibrosarcoma cells by tumor-enhancing IgG 2 in vitro. Transplant Proc (1973) 0.79
Expression of human immunodeficiency virus antigens in an attenuated Salmonella typhi vector vaccine. Dev Biol Stand (1994) 0.79
Stimulation of HIV gp120-specific cytolytic T lymphocyte responses in vitro and in vivo using a detoxified pertussis toxin vector. AIDS Res Hum Retroviruses (2001) 0.78
Composite activities on B cells of products released by T cells activated by concanavalin A. Eur J Immunol (1979) 0.78
Idiotype profile of an immune response. II. Reversal of the relative dominance of major and minor cross-reactive idiotypes in arsonate-specific T-independent responses. J Exp Med (1983) 0.78
Adherence-mediated T cell activation in multiple sclerosis and other neurological disorders. J Neuroimmunol (1994) 0.77
Antigen structure and lymphocyte activation. Immunol Rev (1978) 0.77
Arsonate-specific murine T cell clones. II. Delayed-type hypersensitivity induced by P-azobenzenearsonate-L-tyrosine (ABA-Tyr). J Immunol (1985) 0.77
HV(MNE), a novel lymphocryptovirus related to Epstein-Barr virus, induces lymphoma in New Zealand White rabbits. Blood (2001) 0.77
Oral bacterial vaccine vectors for the delivery of subunit and nucleic acid vaccines to the organized lymphoid tissue of the intestine. Behring Inst Mitt (1997) 0.76
Absence of high-affinity binding sites for interferon alpha/beta in variant murine CD4+ T lymphocytes not expressing the T cell antigen receptor. J Interferon Cytokine Res (1995) 0.76
Arsonate-specific murine T cell clones. III. Correlation between clonotype expression and fine specificity for analogs of L-tyrosine-p-azobenzenearsonate. J Immunol (1986) 0.76
Antigen structural requirements for immunoglobulin isotype switching in mice. J Exp Med (1980) 0.75
The role of immunoglobulin receptors and T cell mediators in B lymphocyte activation. I. B cell activation by anti-immunoglobulin and anti-idiotype reagents. J Immunol (1980) 0.75
Characterization of the binding of radioiodinated hybrid recombinant IFN-alpha A/D to murine and human lymphoid cell lines. J Interferon Res (1990) 0.75
Carcinoma of the lip. J Int Coll Surg (1965) 0.75
Idiotypic properties of the murine anti-arsonate antibody response: B- and T-cell influences. Cell Immunol (1985) 0.75
T-lymphocyte activation by immunogenic determinants. Adv Exp Med Biol (1978) 0.75
Effects of human salivas on recombinant HIV-1 proteins. Crit Rev Oral Biol Med (1993) 0.75
Anti-idiotypic specificity of T cell help induced by concanavalin A. Int Arch Allergy Appl Immunol (1981) 0.75
Mechanisms of immunological enhancement. Prog Exp Tumor Res (1974) 0.75
Idiotype connection between anti-arsonate and anti-dinitrophenyl responses in BALB/c mice. Ann N Y Acad Sci (1983) 0.75
Differential induction of help and suppression in mice by bifunctional antigens administered via different routes. Mol Immunol (1984) 0.75
Thallium-201: scintillation camera imaging considerations. J Nucl Med (1976) 0.75
A patient-centered medication administration system. N C Med J (1983) 0.75
Strange connections in the unspecific parallel set. Surv Immunol Res (1982) 0.75
A simple magnifier-rotator for enhanced visualization of nuclear medicine images. Phys Med Biol (1977) 0.75